Fast, accurate laboratory confirmation turns a suspected outbreak into a response. SECURE-Nigeria strengthened both the laboratories and the way their results reach the national disease reporting system.
Nigeria’s 2017 Joint External Evaluation found that laboratory results travelled separately from disease reports, with long delays. SECURE-Nigeria set out to strengthen national and state laboratories to diagnose priority diseases using molecular tests, and to bring laboratory information into the surveillance system.
The project expanded polymerase chain reaction (PCR) testing, a molecular test that detects a pathogen’s genetic material, for 11 priority diseases in seven national and state laboratories. It set up tests at the National Reference Laboratory in Abuja that check one sample for several pathogens at once, created a back-up biorepository in Lagos, and redesigned how laboratory results are recorded and linked to cases in SORMAS.
Scaled up PCR testing for 11 priority diseases: [list diseases: confirm].
Tests at the National Reference Laboratory check one sample for several pathogens at once, supporting surveillance of patients with sudden fever. Sentinel hospitals test for dengue and chikungunya on site.
Using multiplex bead assay technology, which measures antibodies to several targets at once, the National Reference Laboratory tested 42,820 leftover HIV viral load samples from Nigeria’s six geopolitical zones, 15,252 dried blood spots from antenatal clinics in four states, and 2,152 samples from health workers in Rivers, Oyo and Plateau.
Set up a working biorepository at the Central Public Health Laboratory in Yaba, Lagos, as a campus of the National Reference Laboratory, to store a back-up of the country’s biological samples.
Equipped the laboratory at the Infectious Disease Hospital in Akure with a Class III biosafety cabinet (a sealed glove box for handling dangerous samples safely) and haematology and chemistry analysers, and trained laboratory scientists in quality management. Since March 2025 the hospital can confirm Lassa fever on site instead of sending samples to Owo. Ondo State accounted for 32% of Nigeria’s confirmed Lassa fever cases in 2023.
Set up quality control and external quality assessment (proficiency testing) programmes so laboratories can show their results are accurate.
Expanded influenza testing to include other respiratory infections: whooping cough (pertussis) and diphtheria.
Supported genetic sequencing of the virus that causes COVID-19.
Laboratory records now link to the right case automatically by EPID number, capture every detail on the national paper forms, and are checked for logical dates and the correct state.
Seven laboratories can confirm 11 priority diseases by PCR, so public health action can start sooner.
More than 60,000 samples tested for antibodies across different population groups and regions.
A second biorepository site protects the national collection of biological samples.
Better linking of laboratory results to cases improves confidence in measures such as how long results take and what share of tests are positive.